Hypertriglyceridemia is associated with long-term risk of cardiovascular events and specific comorbidity in very high-risk hypertensive patients
Although hypertriglyceridemia (HTG) frequently occurs in hypertensive patients and may increase cardiovascular risk, the need for and manner of its reduction remain controversial. The objectives of this study were to compare lipid profiles, parameters of glucose homeostasis, comorbidity, and 5-year...
Main Authors: | O. Ya. Korolyuk, O. M. Radchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
2020-04-01
|
Series: | The Ukrainian Biochemical Journal |
Subjects: | |
Online Access: | http://ukrbiochemjournal.org/wp-content/uploads/2020/04/Korolyuk_2_20.pdf |
Similar Items
-
Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis
by: Yan-yan Qi, et al.
Published: (2021-01-01) -
Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ji Eun Jun, et al.
Published: (2020-02-01) -
The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis
by: Murad M Hassan, et al.
Published: (2012-03-01) -
Association of hypertriglyceridemia with risk factors for cardiovascular and renal complications in individuals with high cardiovascular risk
by: I. T. Murkamilov, et al.
Published: (2023-03-01) -
Severe hypertriglyceridemia after use of bempedoic acid
by: Valentin Bovy, et al.
Published: (2023-04-01)